Response Genetics, Inc (RGDXQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2015 | 6.37 Million USD | -34.08% |
| 2014 | 9.66 Million USD | 647.36% |
| 2013 | 1.29 Million USD | 4.11% |
| 2012 | 1.24 Million USD | -10.62% |
| 2011 | 1.39 Million USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 716.85 Thousand USD | 0.0% |
| 2005 | 716.85 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2015 FY | 6.37 Million USD | -34.08% |
| 2015 Q1 | 10.94 Million USD | 13.19% |
| 2014 FY | 9.66 Million USD | 647.36% |
| 2014 Q1 | 1.24 Million USD | -3.71% |
| 2014 Q2 | 1.69 Million USD | 36.16% |
| 2014 Q3 | 9.65 Million USD | 469.38% |
| 2014 Q4 | 9.66 Million USD | 0.12% |
| 2013 Q1 | 1.2 Million USD | -3.16% |
| 2013 Q4 | 1.29 Million USD | -4.05% |
| 2013 FY | 1.29 Million USD | 4.11% |
| 2013 Q2 | 1.39 Million USD | 15.73% |
| 2013 Q3 | 1.34 Million USD | -3.18% |
| 2012 Q4 | 1.24 Million USD | -2.99% |
| 2012 Q2 | 1.31 Million USD | -2.69% |
| 2012 Q1 | 1.35 Million USD | -2.56% |
| 2012 FY | 1.24 Million USD | -10.62% |
| 2012 Q3 | 1.28 Million USD | -2.83% |
| 2011 FY | 1.39 Million USD | 0.0% |
| 2011 Q4 | 1.39 Million USD | 322.6% |
| 2011 Q3 | 328.95 Thousand USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | -100.0% |
| 2007 Q1 | 716.85 Thousand USD | 0.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 FY | 716.85 Thousand USD | 0.0% |
| 2006 Q4 | 716.85 Thousand USD | 0.0% |
| 2006 Q3 | 716.85 Thousand USD | 0.0% |
| 2005 FY | 716.85 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | -184.509% |
| Arrayit Corporation | 1.07 Million USD | -491.096% |
| Atlantic International Corp. | 2.93 Million USD | -117.472% |
| Biocept, Inc. | 12.1 Million USD | 47.37% |
| Bioqual, Inc. | 3.58 Million USD | -77.67% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -8676.544% |
| DermTech, Inc. | 54.39 Million USD | 88.284% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 98.649% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | -31.838% |
| iMD Companies, Inc. | 1.12 Million USD | -468.942% |
| IDenta Corp. | 789.14 Thousand USD | -707.582% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 43.058% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -14435.295% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 20.782% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | -66.576% |
| NovelStem International Corp. | 3.57 Million USD | -78.286% |
| Optigenex Inc. | 8.94 Million USD | 28.72% |
| PharmChem, Inc. | 77.35 Thousand USD | -8138.853% |
| Proteome Sciences plc | 17.15 Million USD | 62.848% |
| Rennova Health, Inc. | 15.32 Million USD | 58.426% |
| RushNet, Inc. | 4.82 Million USD | -32.135% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -2978.238% |
| Stella Diagnostics Inc. | 6.2 Million USD | -2.779% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | -254.039% |
| Todos Medical Ltd. | 38.34 Million USD | 83.381% |